维普中文期刊产品整合服务
91篇 您的检索式:作者名="Stephen M Y"
    题名 作者 年代 出处 被引量
1Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010显示文摘Rafael Lozano Mohsen Naghavi Kyle Foreman Stephen Lim Kenji Shibuya Victor Aboyans Jerry Abraham Timothy Adair Rakesh Aggarwal Stephanie Y Ahn Mohammad A AlMazroa Miriam Alvarado H Ross Anderson Laurie M Anderson Kathryn G Andrews Charles Atkinson Larry M 2012The Lancet . 2012 (9859)2012,,9859:7
2Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010显示文摘Rafael Lozano Mohsen Naghavi Kyle Foreman Stephen Lim Kenji Shibuya Victor Aboyans Jerry Abraham Timothy Adair Rakesh Aggarwal Stephanie Y Ahn Mohammad A AlMazroa Miriam Alvarado H Ross Anderson Laurie M Anderson Kathryn G Andrews Charles Atkinson Larry M 2012The Lancet2012,,9859:5
3Labeling of influenza viruses with synthetic fluorescent and biotin-labeled lipids显示文摘Direct labeling of virus particles is a powerful tool for the visualization of virus–cell interaction events. However, this technique involves the chemical modification of viral proteins that affects viral biological properties. Here we describe an alternative approach of influenza virus labeling that utilizes Function-Spacer-Lipid(FSL) constructs that can be gently inserted into the virus membrane. We assessed whether labeling with fluorescent(fluo-Ad-DOPE) or biotin-labeled(biot-CMG2-DOPE) probes has any deleterious effect on influenza virus hemagglutinin(HA) receptor specificity, neuraminidase(NA) activity, or replicative ability in vitro. Our data clearly show that neither construct significantly affected influenza virus infectivity or viral affinity to sialyl receptors. Neither construct influenced the NA activities of the influenza viruses tested, except the A/Puerto Rico/8/34(H1N1) strain. Our data indicate that lipid labeling provides a powerful tool to analyze influenza virus infection in vitro.Natalia A Ilyushina Evgeny S Chernyy Elena Y Korchagina Aleksra S Gambaryan Stephen M Henry Nicolai V Bovin 2014Virologica Sinica2014,29,4:2
4Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010显示文摘Rafael Lozano Mohsen Naghavi Kyle Foreman Stephen Lim Kenji Shibuya Victor Aboyans Jerry Abraham Timothy Adair Rakesh Aggarwal Stephanie Y Ahn Mohammad A AlMazroa Miriam Alvarado H Ross Anderson Laurie M Anderson Kathryn G Andrews Charles Atkinson Larry M 20122012 (9859)2012,,9859:2
5Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing显示文摘Chan K C Allen Jiang Peiyong Zheng Yama W L Liao Gary J W Sun Hao Wong John Siu Shing Shun N Chan Wing C Chan Stephen L Chan Anthony T C Lai Paul B S Chiu Rossa W K Lo Y M D 2013Clinical Chemistry2013,,1:2
6Strategic outsourcing for competing OEMs that face cost reduction opportunities 显示文摘Stephen G M Xia Y S Yu G 2006IIE Transactions2006,38,11:1
7Hematopoietic stem cells convert into liver cells within days without fusion 显示文摘JANG Y Y STEPHEN B B ANNA M D 2004Nature Cell Biolo2004,6,6:1
8A numerical study of flow and heat transfer in a smooth and ribbed U-duct with and without rotation显示文摘LIN Y L SHIH T I P STEPHENS M A 2001Journal of Heat Transfer2001,123,:1
9Intermediate temperature joining of dissimilar metals显示文摘Hosking Y F M Stephens J J Rejent J A 1996Welding Research1996,4,:1
10Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats显示文摘Sakaguchi Y Stephens LC Makino M 1995Cancer Res1995,55,22:1
11Two-state option pricing:binomial models revisited显示文摘Gerge M J Marat V K Stephen D Y 2002The Journal of Futures Markets2002,22,60:1
12System response function: a new approach to minimize IR testing errors显示文摘Stephen W M Dave A G Eden Y M 1990SPIE1990,1309,:1
13Neoadjuvant Therapy for Breast Cancer显示文摘Stephen L Laleh M Kathy Y 0,,04:1
14Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase Ⅱ randomised placebo-controlled double-blind multicentre trial显示文摘Rationale Haematoma growth is common early after intracerebral haemorrhage(ICH),and is a key determinant of outcome.Tranexamic acid,a widely available antifibrinolytic agent with an excellent safety profile,may reduce haematoma growth.Methods and design Stopping intracerebral haemorrhage with tranexamic acid for hyperacute onset presentation including mobile stroke units(STOP-MSU)is a phase Ⅱ double-blind,randomised,placebo-controlled,multicentre,international investigator-led clinical trial,conducted within the estimand statistical framework.Hypothesis In patients with spontaneous ICH,treatment with tranexamic acid within 2 hours of onset will reduce haematoma expansion compared with placebo.Sample size estimates A sample size of 180 patients(90 in each arm)would be required to detect an absolute difference in the primary outcome of 20%(placebo 39%vs treatment 19%)under a two-tailed significance level of 0.05.An adaptive sample size re-estimation based on the outcomes of 144 patients will allow a possible increase to a prespecified maximum of 326 patients.Intervention Participants will receive 1 g intravenous tranexamic acid over 10 min,followed by 1 g intravenous tranexamic acid over 8 hours;or matching placebo.Primary efficacy measure The primary efficacy measure is the proportion of patients with haematoma growth by 24±6 hours,defined as either≥33%relative increase or≥6 mL absolute increase in haematoma volume between baseline and follow-up CT scan.Discussion We describe the rationale and protocol of STOP-MSU,a phase Ⅱ trial of tranexamic acid in patients with ICH within 2 hours from onset,based in participating mobile stroke units and emergency departments.Nawaf Yassi Henry Zhao Leonid Churilov Bruce C V Campbell Teddy Wu Henry Ma Andrew Cheung Timothy Kleinig Helen Brown Philip Choi Jiann-Shing Jeng Annemarei Ranta Hao-Kuang Wang Geoffrey C Cloud Rohan Grimley Darshan Shah Neil Spratt Der-Yang Cho Karim Mahawish Lauren Sanders John Worthington Ben Clissold Atte Meretoja Vignan Yogendrakumar Mai Duy Ton Duc Phuc Dang Nguyen Thai My Phuong Huy-Thang Nguyen Chung Y Hsu Gagan Sharma Peter J Mitchell Bernard Yan Mark W Parsons Christopher Levi Geoffrey A Donnan Stephen M Davis 2022Stroke & Vascular Neurology2022,7,2:1
15A new strategy for harnessing knowledge management in e-commerce显示文摘STEPHEN A O DAVID C Y JEFFREY W M 2005Technology in Society2005,27,:1
16A comparison of bayesian methods for haplotype reconstruction from population genotype data显示文摘Stephens M Donnel]y P 2003Am J Hum Genet2003,73,5:1
17CRH-R1 is significantly up-regulated at the time of labor in the human myometrium显示文摘Stevens M Y Jones R G C Stephen J L 1998J Clin Endocrinol Metab1998,83,:1
18Neoadjuvant Therapy Breast Canc- er显示文摘Stephen L laleh M Kathy Y 2010J Surg Oncol2010,101,4:1
19RNA-Seq:An assessment of technical reproducibility andcomparison with gene expression arrays显示文摘Marioni J C Mason C E Mane S M Stephens M Gilad Y 2008Genome Research2008,18,9:1
20Apoptosis in tumor and normal tissues induced by whole body hyperthermia in rats显示文摘Sakaguchi Y Stephens L C Makino M 1995Cancer Res1995,55,1:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费